Global Health Campus,
Chemin du Pommier 40,
1218 Le Grand-Saconnex, Geneva, Switzerland

Annex G - GDF access to supplier information for WHO PQP and ERP assessed TB medicines ITB-Iplus/GDF-MED/2023/2

Annex F - CDP Technical Tender Submission - Instructions for use ITB-Iplus/GDF-MED/2023/2

Annex E - i+solutions Code of Conduct for Suppliers ITB-Iplus/GDF-MED/2023/2

Annex D - i+solutions model long-term agreement (LTA) ITB-Iplus/GDF-MED/2023/2

Annex C- List of priority countries for TB medicines registration ITB-Iplus/GDF-MED/2023/2

Annex B - List and technical specifications of products requested ITB-Iplus/GDF-MED/2023/2

Annex A - Financial Bid Response Form ITB-Iplus/GDF-MED/2023/2

ITB-Iplus/GDF-MED/2023/2

Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study
Leddy A, Ggita J, Berger C, Kityamuwesi A, Sanyu A, Tinka L, Crowder R, Turyahabwe S, Katamba A, Cattamanchi A

Pooling sputum testing to diagnose tuberculosis using xpert MTB/RIF and xpert ultra: a cost-effectiveness analysis
Iem V, Bimba JS, Santos VS, Dominguez J, Creswell J, Somphavong S, Wingfield T, Khan JAM, Cuevas LE.
Pagination
- Previous page
- Page 19
- Next page